YOLFTbeta
Pharming Group NV

Pharming Group NV

PHARM · AS · Healthcare / Biotechnology

0.8624EUR+0.00 (+0.26%)

Price History

Full chart

Market Stats

Previous Close0.8602
Open0.848
Day Range0.8447 – 0.8624
52-Week Range0.8338 – 1.82
Volume5.41M
Market Cap618.74M
P/E (TTM)87.42
Forward P/E200.00
EPS0.01
Dividend Yield0.00%
Beta0.07
50-Day Avg0.9614
200-Day Avg1.24

About

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K" inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Fabrice Chouraqui M.B.A., Ph.D., Pharm.D.
  • Employees407
  • HeadquartersDarwinweg 24, Leiden, Netherlands, 2333 CR, Netherlands
  • Websitehttps://www.pharming.com

Leadership

  • Mr. Fabrice Chouraqui M.B.A., Ph.D., Pharm.D.CEO & Executive Director
  • Mr. Kenneth Lynard EMBA, M.Sc.Chief Financial Officer · b. 1968
  • Ms. Mireille Sanders M.Sc.Chief Operations Officer · b. 1968
  • Mr. Michael K. LevitanVP of Investor Relations & Corporate Communications
  • Mr. Ruud Van Outersterp L.L.M.Chief Legal & Compliance Officer and Company Secretary · b. 1964
  • Ms. Ines Bernal B.A.Chief People Officer
  • Dr. Anurag Relan M.D., MPHChief Medical Officer · b. 1972
  • Dr. Alexander Breidenbach M.B.A., Ph.D.Chief Business Officer · b. 1963
  • Ms. Leverne Marsh BPHARMChief Commercial Officer
  • Dr. Magnus HanssonMedical Director · b. 1976

Financials

Income Statement

Line item2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue652.72K479.68K194.01K1.01M924.35K1.57M762.07K3.89M14.04M9.45M25.76M11.84M16.69M107.52M154.58M189.33M228.39M189.85M205.62M226.91M297.07M376.13M
Cost of Revenue5.77M6.17M5.97M36.90M1.42M5.24M121.03K4.58M5.64M1.54M4.17M5.25M4.93M14.93M25.37M23.92M25.34M20.18M17.56M33.50M35.40M45.50M
Gross Profit-5.12M-5.69M194.01K-35.90M924.35K1.57M641.04K-688.23K8.39M7.92M21.60M6.59M11.77M92.59M129.20M165.41M203.06M169.67M188.06M193.41M261.80M330.63M
Operating Income-14.53M-21.84M-23.80M-35.90M-41.02M-39.90M-58.69M-23.98M-23.09M-9.54M3.50M-14.03M-12.14M26.29M43.46M68.23M82.09M27.84M18.23M-20.38M-3.67M20.88M
EBITDA-13.38M-19.86M-20.70M-47.90M-33.69M-33.29M-46.46M-24.13M-25.97M-15.83M3.72M-14.75M-13.95M-39.81M50.98M75.41M92.11M46.56M32.61M-10.20M13.65M34.78M
Net Income-14.20M-21.15M-24.41M-51.92M-36.48M-45.93M-74.97M-22.17M-31.86M-20.80M-7.01M-10.89M-18.44M-95.92M28.59M40.54M37.75M16.00M13.67M-9.76M-11.84M2.97M
R&D5.47M10.57M11.10M27.83M29.03M35.14M28.14M17.92M25.59M14.13M14.18M15.50M16.18M22.38M33.04M31.78M41.46M67.18M52.53M60.14M75.97M100.37M
Interest Expense8.99K10.66K1.71M1.94M1.87M11.87M6.67M276.07K3.43M4.54M212.80K135.57K3.77M21.28M16.37M13.35M6.40M5.92M5.36M5.96M9.05M10.72M

Balance Sheet

Line item2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-40.96M104.37M166.72M93.40M80.07M49.59M32.01M22.28M43.37M67.75M63.06M133.34M199.38M245.45M255.63M419.12M396.90M425.80M426.34M400.61M500.02M
Total Liabilities-6.93M38.59M116.14M75.96M60.99M36.16M33.55M32.40M36.45M31.46M37.00M104.45M176.82M174.81M138.38M235.39M204.19M221.16M228.28M178.85M222.89M
Total Equity-34.04M65.78M50.58M17.45M19.07M14.45M-1.54M-10.12M6.92M36.29M26.06M28.89M22.56M70.64M117.26M183.73M192.72M204.64M198.05M221.76M277.10M
Cash-17.40M34.42M74.29M27.30M22.81M13.70M4.90M6.97M23.43M41.57M34.60M33.54M70.37M91.87M74.27M205.49M191.72M207.34M55.89M54.92M146.08M
Total Debt-223.85K2.08M22.92M52.57M41.96M236.00K4.45M3.78M2.72M1.93M17.35M70.88M97.53M83.42M58.14M162.22M161.59M166.69M155.29M112.26M115.79M
Net Debt--17.17M-32.34M-51.37M25.27M19.15M-13.70M-445.86K-3.20M-20.71M-39.63M-17.25M37.34M27.16M-8.44M-16.13M-43.27M-30.13M-40.65M99.40M57.34M-30.29M

Cash Flow

Line item2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-10.28M-15.26M-25.89M-31.69M-14.21M-27.24M-6.89M-20.34M-13.58M-11.45M-6.42M-17.95M-10.52M45.84M46.19M74.56M90.98M36.13M22.90M-19.55M-1.86M51.96M
Investing Cash Flow-5.16M-3.43M-4.22M-978.32K-1.13M6.02M-1.21M-1.42M142.83K241.00K-654.00K-898.00K-57.47M-6.04M-3.77M-28.26M-15.63M-21.30M5.32M-129.39M32.74M19.13M
Financing Cash Flow34.44M10.29M45.38M84.04M-26.19M3.54M17.15M16.40M15.30M29.12M21.88M15.70M70.81M-3.91M-20.55M-62.32M65.33M-26.68M-4.98M2.78M-35.63M15.03M
Capital Expenditure546.76K1.02M4.16M978.32K1.13M435.56K1.21M1.37M812.02K29.00K187.27K981.79K1.59M7.25M4.31M25.44M16.47M15.96M1.98M1.35M789.65K779.53K
Free Cash Flow-10.82M-16.28M-30.05M-32.67M-15.35M-27.68M-8.09M-21.71M-14.39M-11.48M-6.61M-18.94M-12.11M38.59M41.87M49.11M74.51M20.17M20.92M-20.90M-2.58M51.18M
Dividends Paid-------------0-0000000

Earnings

Report DateNov 3, 2005Oct 27, 2006Feb 16, 2007Apr 20, 2007Jul 19, 2007Oct 19, 2007Feb 15, 2008Apr 18, 2008Jul 18, 2008Oct 17, 2008Feb 13, 2009Apr 17, 2009Jul 17, 2009Oct 16, 2009Feb 18, 2010Apr 22, 2010Jul 21, 2010Oct 21, 2010Mar 3, 2011May 12, 2011Aug 4, 2011Nov 17, 2011Mar 1, 2012Apr 26, 2012Aug 23, 2012Nov 1, 2012Mar 7, 2013May 16, 2013Aug 1, 2013Nov 7, 2013Mar 6, 2014May 15, 2014Jul 31, 2014Oct 30, 2014Mar 5, 2015Apr 30, 2015Jul 30, 2015Oct 28, 2015Mar 10, 2016May 18, 2016Jul 28, 2016Oct 27, 2016Mar 9, 2017May 17, 2017Jul 27, 2017Oct 26, 2017Mar 7, 2018May 17, 2018Jul 26, 2018Oct 25, 2018Mar 7, 2019May 16, 2019Jul 25, 2019Oct 24, 2019Mar 5, 2020May 14, 2020Jul 30, 2020Oct 29, 2020Mar 4, 2021May 13, 2021Aug 4, 2021Oct 28, 2021Mar 17, 2022May 12, 2022Aug 4, 2022Oct 27, 2022Mar 16, 2023May 11, 2023Aug 3, 2023Oct 26, 2023Mar 14, 2024May 8, 2024Aug 1, 2024Oct 24, 2024Mar 13, 2025May 8, 2025Jul 31, 2025Nov 6, 2025Mar 12, 2026May 6, 2026Jul 30, 2026Nov 5, 2026
EPS Estimate-0.72-0.63-0.65--0.69---1.28-1.11--------0.39-0.26------------0.02-0.07-0.01-0.050.040.04-0.01---0.01-0.01-0.01-0.01-0.01--0.02-0.01-0.010.010.010.010.020.010.010.010.010.020.020.020.010.010.010.010.020.020.010.010.01-0.010.01-0.030.010.010.01---0.01--0.01--0.01
EPS Actual-0.60-0.62-1.04-0.55-0.97-0.70-1.99-1.10-1.43-0.79-0.39-0.62-0.89-0.70-0.60-0.49-2.43-0.28-0.40-0.08-0.10-0.12-0.08-0.12-0.17-0.120.00-0.05-0.01-0.02-0.02-0.04-0.010.000.04-0.00-0.01-0.01-0.01-0.01-0.01-0.01-0.02-0.01-0.06-0.02-0.080.010.010.010.020.010.010.020.020.020.010.010.020.010.010.010.010.010.020.01-0.02-0.020.000.01-0.00-0.02-0.00-0.000.01-0.020.010.010.01-0.010.00-
Surprise16.67%1.59%-60.00%--40.58%--14.06%-28.83%--------523.08%-7.69%-----------0.00%71.43%-342.00%79.80%-92.25%0.00%68.00%--0.00%0.00%0.00%0.00%-100.00%--200.00%-100.00%-700.00%0.00%0.00%0.00%0.00%0.00%0.00%100.00%100.00%0.00%-50.00%-50.00%100.00%0.00%0.00%-28.57%-50.00%-50.00%100.00%0.00%-300.00%-100.00%-82.00%133.33%-137.00%-300.00%-116.00%---100.00%--0.00%---
TimingPre-marketPre-market--After-hours--Pre-marketPre-market-------Pre-marketPre-market---------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-market

Key Statistics & Ratios

Market Cap618.74M
Enterprise Value626.87M
Trailing P/E87.42
Forward P/E200.00
PEG Ratio0.00
Price / Sales1.69
Price / Book2.82
EPS0.01
Book Value0.3284
Revenue (TTM)366.48M
Gross Profit (TTM)317.08M
EBITDA32.88M
Profit Margin2.54%
Operating Margin1.46%
Return on Equity3.65%
Return on Assets3.47%
Shares Outstanding707.78M
Shares Float696.57M
Beta0.07
Dividend Yield0.00%
Dividend Rate0
Payout Ratio0.00%

Stock Splits

  • Nov 23, 2016805:799
  • Mar 5, 20131:10